GenNext Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

GenNext Technologies is a private company founded in 2016, commercializing an innovative platform for protein structural analysis. Its core Fox technology enables high-resolution, in-solution mapping of protein-protein interactions, epitopes, and conformational changes, which is crucial for developing safe and effective biologics, including AI-discovered candidates. The company operates a hybrid business model, selling its automated AutoFox system and FoxWare software while also offering fee-for-service structural biology studies. Strategic collaborations with major players like Thermo Fisher, Agilent, and SCIEX position it to become a key enabler in modern structural biology workflows.

AI / Machine LearningDrug Delivery

Technology Platform

Fox® Protein Footprinting platform using hydroxyl radicals for residue-level analysis of protein higher-order structure and dynamics in solution. Includes the automated AutoFox® benchtop instrument and FoxWare® data analysis software.

Opportunities

The rapid growth of complex biologics and AI-driven drug discovery creates a strong demand for high-resolution, dynamic protein structural data.

Strategic partnerships with major instrument vendors (Thermo Fisher, Agilent, SCIEX) provide powerful channels for market penetration and co-development.

Risk Factors

Adoption risk for a novel analytical technique in a conservative industry; competition from established HOS methods like HDX-MS and specialized CROs; and execution risks related to scaling hardware manufacturing, software development, and service delivery simultaneously.

Competitive Landscape

GenNext competes with providers of established protein HOS analysis techniques, primarily Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) offered by companies like Waters Corporation and specialized CROs. It also competes with other biophysical methods (SPR, BLI, CD) and synchrotron-based footprinting services. Its differentiation lies in automation, resolution in complex matrices, and direct measurement of solvent accessibility.

More companies in Proteomics & Protein Engineering →More companies in United States →